Glucan phosphate attenuates myocardial HMGB1 translocation in severe sepsis through inhibiting NF-κB activation.
about
Innate immunity and cardiomyocytes in ischemic heart diseaseNovel Mechanisms of Herbal Therapies for Inhibiting HMGB1 Secretion or ActionHMGB1 in health and disease.The compromise of macrophage functions by hyperoxia is attenuated by ethacrynic acid via inhibition of NF-κB-mediated release of high-mobility group box-1.Continuous hemodiafiltration therapy reduces damage of multi-organs by ameliorating of HMGB1/TLR4/NFκB in a dog sepsis modelAn ongoing search for potential targets and therapies for lethal sepsisPrunella vulgaris aqueous extract attenuates IL-1β-induced apoptosis and NF-κB activation in INS-1 cells.Tanshinone IIA sodium sulfonate facilitates endocytic HMGB1 uptakePuerarin attenuates the inflammatory response and apoptosis in LPS-stimulated cardiomyocytes.Relationship between vascular reactivity and expression of HMGB1 in a rat model of septic aorta.Targeting HMGB1 in the treatment of sepsisThe Effect of Systemic Carnitine Administration on Colon Anastomosis Healing in an Experimental Sepsis Model.Glutamine ameliorates lipopolysaccharide-induced cardiac dysfunction by regulating the toll-like receptor 4/mitogen-activated protein kinase/nuclear factor-kB signaling pathway.Treatment of low molecular weight heparin inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in rats.Abnormal expression of Toll-like receptor 4 is associated with susceptibility to ethanol-induced gastric mucosal injury in mice.Fisetin administration improves LPS-induced acute otitis media in mouse in vivo.
P2860
Q27003911-CEFDE9E0-F708-45AD-AA79-EDFCD9D0A2A3Q27009468-5D077374-A9E9-4843-845A-0DC8229F0FFCQ34622835-FBE8B6D0-BD76-48B2-93C8-5C361A55FC1CQ35207661-7753C96E-6FB8-4422-9C9E-1BA5D143D3B2Q35406770-023F2CDC-3566-4972-9650-28375A9F263EQ35930160-CFE8BD1E-E16C-483D-9751-2E6AEDD68948Q36224347-66B62F1D-A4CC-400F-B5C2-AC51874465BFQ36377158-AD8491EB-BB3E-4043-A621-6F5818ED99B4Q36524467-D7AEC931-7359-49B1-91FD-2AF6EDCC5E1AQ37300315-A2A9BF06-9C43-4AB9-A9A1-18C643A93408Q37622744-47FF00F6-2CFE-4397-977A-90360D98BE69Q41054654-7BDFD79D-32CD-4C81-AFC0-4E6C873B7454Q47131473-6823EB33-5D04-4DDD-B4F8-D94F36A1701DQ47188763-79D18BB4-1833-4322-8F5E-FD32B7E613E0Q50929363-C00C0165-D6FE-475E-928E-86BA4406A183Q52641331-709C7281-6CCA-4D14-AC87-B15CF0AFA30E
P2860
Glucan phosphate attenuates myocardial HMGB1 translocation in severe sepsis through inhibiting NF-κB activation.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Glucan phosphate attenuates my ...... h inhibiting NF-κB activation.
@ast
Glucan phosphate attenuates my ...... h inhibiting NF-κB activation.
@en
type
label
Glucan phosphate attenuates my ...... h inhibiting NF-κB activation.
@ast
Glucan phosphate attenuates my ...... h inhibiting NF-κB activation.
@en
prefLabel
Glucan phosphate attenuates my ...... h inhibiting NF-κB activation.
@ast
Glucan phosphate attenuates my ...... h inhibiting NF-κB activation.
@en
P2093
P2860
P1476
Glucan phosphate attenuates my ...... h inhibiting NF-κB activation.
@en
P2093
Chuanfu Li
David L Williams
Jim Kelley
John Kalbfleisch
Race L Kao
Tuanzhu Ha
Yeling Xia
P2860
P304
P356
10.1152/AJPHEART.01007.2010
P577
2011-06-03T00:00:00Z